SLC35B2 and infection: Treatment with sodium chlorate, a specific inhibitor of the universal sulfate donor 3’-phosphoadenosine-5’-phosphosulfate (PAPS) synthesis [35], and the knockout of SLC35B2, a Golgi-resident transporter of PAPS, demonstrated the importance of sulfation for efficient infection with high and low affinity variants.